Merge Healthcare to sell up to 9,034,033 shares of common stock to institutional investors

Merge Healthcare (NASDAQ: MRGE) (“Merge”) announced today that it is offering to sell up to 9,034,033 shares of common stock in a registered direct offering to select institutional investors at a purchase price of $3.00 per share. Merge expects to enter into definitive agreements with respect to this offering later today.

A shelf registration statement, as amended, relating to these securities was previously filed on September 3, 2009 and declared effective by the Securities and Exchange Commission. A free writing prospectus was filed today with the Securities and Exchange Commission. A prospectus supplement related to the offering will be filed with the Securities and Exchange Commission. This press release does not constitute an offer to sell or the solicitation of offers to buy any security and shall not constitute an offer, solicitation, or sale of any security in any jurisdiction in which such offer, solicitation, or sale would be unlawful. Any offer will be made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A copy of the prospectus supplement and accompanying base prospectus can be obtained at the Securities and Exchange Commission's website http://www.sec.gov or via written request to Merge Healthcare Incorporated, 6737 W. Washington Street, Suite 2250, Milwaukee, Wisconsin 53214, Attn: General Counsel. Alternatively, the issuer will arrange to send you these documents if you request them by calling 414.977.4067.